Shanghai

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Hidradenitis suppurativa2 trials
• Multiple myeloma1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Sanofi3 trials

Running trials

• Recruiting

  A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT07225569· Phase 2· Sanofi· Source

• Recruiting

  Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

  NCT07170917· Phase 2· Sanofi· Source

• Active, not recruiting

  Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

  NCT04270409· Phase 3· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa2 recruiting